Indian Patent Grant Overview:
Bespoke Bone Graft Invention
An official Patent Certificate has been issued by the Intellectual Property Office, Government of India, under the provisions of the Patents Act, 1970. This document formally recognises a novel biotechnological advancement in the field of medical therapeutics and bone tissue engineering.
The certificate, identified by Serial Number 044207283, confirms that the statutory requirements established under Rule 74 of The Patents Rules have been successfully met.
Core Patent Information
Technical Title & Scope of Invention
Sr²⁺ and Mg²⁺ Doped Calcium-Deficient Apatite (CDA) as an Angiogenic and Customizable Bespoke Bone Graft
The invention introduces a specialised Calcium-Deficient Apatite (CDA) scaffold structurally modified with strontium (Sr²⁺) and magnesium (Mg²⁺) ions, targeting two major requirements in bone regenerative medicine:
Angiogenic — Promotes blood vessel formation, critical for delivering nutrients to regenerating bone tissues.
Bespoke — Customisable to the precise anatomical defects of individual patients for tailored clinical outcomes.
Legal Term & Maintenance
The Controller of Patents has granted a legal exclusivity term of 20 years from the original date of filing — beginning 3 March 2025.
